A Study to Decipher the Potential Effects of Butylphthalide against Central Nervous System Diseases Based on Network Pharmacology and Molecular Docking Integration Strategy

BACKGROUND: Butylphthalide (NBP), approved by the China National Medical Products Administration (NMPA) for the treatment of ischemic stroke (IS), showed pleiotropic potentials against central nervous system (CNS) diseases, including neuroprotection and cognitive deficits improvement. However, the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qinqin, Zheng, Bei, Feng, Pinpin, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116153/
https://www.ncbi.nlm.nih.gov/pubmed/34035826
http://dx.doi.org/10.1155/2021/6694698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116153/
https://www.ncbi.nlm.nih.gov/pubmed/34035826
http://dx.doi.org/10.1155/2021/6694698

Ejemplares similares